Mulder P O, Sleijfer D T, de Vries E G, Uges D R, Mulder N H
Department of Intensive care Medicine, University Hospital, Groningen, The Netherlands.
J Cancer Res Clin Oncol. 1988;114(2):212-4. doi: 10.1007/BF00417840.
A case history is reported or renal failure during and after treatment with carboplatin for 3 days, total dose 750 mg/m2, in a conditioning regimen prior to autologous bone marrow transplantation. Pretreatment renal function was compromised after nephrectomy and chemotherapy with cisplatin. A decrease in glomerular filtration rate concurred with a decrease in excretion of platinum in the urine and an increase in urinary beta 2 microglobulin. Treatment with high-dose carboplatin in patients with impaired renal function and previous treatment with cisplatin may lead to further loss of renal function.
报告了1例在自体骨髓移植前的预处理方案中,接受卡铂治疗3天、总剂量750mg/m²期间及之后出现肾衰竭的病例。肾切除术后和顺铂化疗后,患者预处理时的肾功能已受损。肾小球滤过率下降的同时,尿铂排泄减少,尿β2微球蛋白增加。肾功能受损且既往接受过顺铂治疗的患者,使用大剂量卡铂治疗可能导致肾功能进一步丧失。